Key facts
- This page summarizes Avara Management Ltd's Form 4 filing for Royalty Pharma plc (RPRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2024, 16:31.
Avara Management Ltd - 29 Dec 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- RPRX
- Reported as of
- 29 Dec 2023
- Net transaction value
- -$1,845,406
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2024, 16:31:02 UTC
- Prior SEC filing
- 29 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- Avara Management Ltd By: GISEV (Suisse) SA, Corporate Director to GS Corp LTD, Corporate Director to Avara /s/ Achille G. Severgnini, Director
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Avara Management Ltd filed Form 4 for Royalty Pharma plc (RPRX) on 03 Jan 2024.
Change
- Previous filing in this sequence was filed on 29 Dec 2023.
- Current net transaction value: -$1,845,406.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RPRX
transaction
Class A Ordinary Shares
Sale
- Transaction value
- $1,845,406
- Shares
- -65,803
- Change %
- -2.6%
- Price
- $28.04
- Shares after
- 2,477,520
- Date
- 29 Dec 2023
- Ownership
- See Footnotes
- Footnotes
- F1, F2, F3
RPRX
holding
Class A Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,795,072
- Date
- 29 Dec 2023
- Ownership
- See Footnotes
- Footnotes
- F3, F4
RPRX
holding
Class A Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 22,225,000
- Date
- 29 Dec 2023
- Ownership
- See Footnotes
- Footnotes
- F3, F5
RPRX
holding
Class A Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 29 Dec 2023
- Ownership
- See Footnotes
- Footnotes
- F3, F6
RPRX
holding
Class A Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,747
- Date
- 29 Dec 2023
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.105 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
Reflects securities held directly by Avara Management Ltd. Avara Management Ltd is wholly-owned by M. Germano Giuliani.
Footnote F3
The Reporting Person may be deemed to beneficially own the securities reported herein directly or indirectly controlled by him, but such Reporting Person (other than the direct holder to the extent of his direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein or is subject to Section 16.
Footnote F4
Reflects securities held directly by Skyeline Management Ltd. Skyeline Management Ltd is wholly-owned by Avara Management Ltd. Avara Management Ltd is wholly-owned by M. Germano Giuliani.
Footnote F5
Reflects securities held directly by MGG Strategic SICAF SIF S.A. - MGG Strategic, a Luxembourg company ("MGG Strategic"). MGG Strategic is a sub-fund managed and administered by MGG Strategic SICAF SIF S.A. ("MGG SICAF"). A board of directors consisting of M. Germano Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by MGG SICAF. Each member of the board disclaims beneficial ownership over such shares. MGG SICAF is owned by the MGG Trust of which M. Germano Giuliani is the beneficiary. The MGG Trust is the 100% economic owner of the shares held by MGG Strategic. M. Germano Giuliani disclaims beneficial ownership over the shares beneficially owned by MGG Strategic. The trustee of the MGG Trust is GISEV Trustees Limited. The protector of the MGG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the MGG Trust.
Footnote F6
Reflects securities held by the spouse of M. Germano Giuliani.